Join Our Priority List

Be the first to hear when our product is available!

Pitt spinoff on insomnia: Cooler heads do prevail

Pitt spinoff on insomnia: Cooler heads do prevail

May 04, 2017

Studies at the University of Pittsburgh found that the brains of patients with insomnia were overactive. Pitt had a patent for a technique to reduce brain metabolic activity using cooling, and Dr. Eric Nofzinger saw the potential.

Read More


Cerêve Raises $38 Million to Fuel Launch of Insomnia Device in New Financing Led by KKR

Cerêve Raises $38 Million to Fuel Launch of Insomnia Device in New Financing Led by KKR

January 06, 2017

Cerêve Inc. (now known as Ebb Therapeutics), a privately-held health care company preparing to launch its FDA-cleared insomnia device, announced today the closing of a $38 million Series B round of financing led by KKR, a leading global investment firm. Also participating in the financing are existing shareholders Versant Ventures, Arboretum Ventures, and Partner Ventures. Read More


FDA Clears Sleep Device for Insomnia

FDA Clears Sleep Device for Insomnia

June 08, 2016

The FDA has granted commercial clearance for the Cerêve Sleep System, a prescription device that reduces latency to stage-1 and stage-2 sleep for people with insomnia.

Read More